Skip to main content
logo
Suzhou Ribo Life Science Co., Ltd. (HKG:6938)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
57.40
-0.30 (-0.52%)
Sep 10, 2026, 11:37 AM HKT

Suzhou Ribo Life Science Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2019FY 2018
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '19 Dec '18
Revenue
464.43148.51142.630.04--
Revenue Growth
212.73%4.13%324052.27%---
Gross Profit
428.03121.73115.65-24.98-1.96-2.44
Operating Income
-117.52-279.32-258.34-422.49-140.39-111.57
Net Income
-169.64-278.06-270.15-428.35-134.35-98.66
Earnings Per Share
-1.12-2.11-2.10-3.34-4.51-3.65
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Overseas
392.83105.41101.05-
Mainland China
71.6143.141.580.04
Total
464.43148.51142.630.04

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2019FY 2018
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '19 Dec '18
Cash & Investments
2,274408.34185.16215.27238.12105.11
Total Debt
542.76550.07428.88414.7476.08-
Net Cash (Debt)
1,731-141.73-243.72-199.47162.04105.11
Net Cash Growth
----54.16%-51.45%
Net Cash Per Share
11.48-1.07-1.89-1.555.443.89

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2019FY 2018
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '19 Dec '18
Operating Cash Flow
--280.69-60.72-287.54-135.14-97.96
Capital Expenditures
--9.89-23.32-40-9.49-13.43
Free Cash Flow
--290.58-84.04-327.53-144.63-111.39
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2019FY 2018
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '19 Dec '18
Gross Margin
92.16%81.96%81.09%---
Operating Margin
-25.30%-188.08%-181.13%-960211.36%--
Pretax Margin
-24.14%-191.61%-180.22%-993518.18%--
Profit Margin
-36.53%-187.23%-189.41%-973520.46%--
FCF Margin
--195.66%-58.92%-744395.46%--